Total Payments
$52,958
2024 Payments
$3,483
Companies
70
Transactions
1,141
Medicare Patients
5,761
Medicare Billing
$1.2M
Payment Breakdown by Category
Research$34,532 (65.2%)
Food & Beverage$18,230 (34.4%)
Consulting$150.00 (0.3%)
Education$28.77 (0.1%)
Other$17.13 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $34,532 | 2 | 65.2% |
| Food and Beverage | $18,230 | 1,134 | 34.4% |
| Consulting Fee | $150.00 | 1 | 0.3% |
| Education | $28.77 | 3 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17.13 | 1 | 0.0% |
Payments by Type
Research
$34,532
2 transactions
General
$18,426
1,139 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $34,532 | 2 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $2,501 | 193 | $0 (2024) |
| ABBVIE INC. | $2,222 | 148 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,779 | 123 | $0 (2024) |
| Lilly USA, LLC | $1,204 | 76 | $0 (2024) |
| Biogen, Inc. | $1,052 | 54 | $0 (2024) |
| Lundbeck LLC | $982.19 | 53 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $878.11 | 52 | $0 (2022) |
| Allergan, Inc. | $520.49 | 47 | $0 (2021) |
| PFIZER INC. | $500.52 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,483 | 200 | ABBVIE INC. ($510.62) |
| 2023 | $3,870 | 216 | AbbVie Inc. ($540.83) |
| 2022 | $3,507 | 220 | ABBVIE INC. ($764.61) |
| 2021 | $6,498 | 140 | Eli Lilly and Company ($4,136) |
| 2020 | $32,443 | 161 | Eli Lilly and Company ($30,396) |
| 2019 | $1,762 | 122 | Teva Pharmaceuticals USA, Inc. ($491.52) |
| 2018 | $763.67 | 41 | Biogen, Inc. ($194.63) |
| 2017 | $630.17 | 41 | Allergan Inc. ($256.94) |
All Payment Transactions
1,141 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/25/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/23/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: PAIN | ||||||
| 12/20/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Analgesic | ||||||
| 12/16/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Central Nervous System | ||||||
| 12/12/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Central Nervous System | ||||||
| 11/14/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $8.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: Neurology | ||||||
| 11/06/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Immune | ||||||
| 10/31/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $33.61 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: Neuroscience | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) | Eli Lilly and Company | $34,532 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,542 | 1,973 | $692,715 | $312,088 |
| 2022 | 7 | 1,526 | 1,971 | $652,525 | $308,057 |
| 2021 | 8 | 1,464 | 1,888 | $596,600 | $296,060 |
| 2020 | 7 | 1,229 | 1,646 | $539,600 | $236,513 |
Total Patients
5,761
Total Services
7,478
Medicare Billing
$1.2M
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 291 | 296 | $296,000 | $122,988 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 736 | 1,136 | $227,200 | $114,970 | 50.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 299 | 299 | $101,660 | $39,959 | 39.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 118 | 141 | $38,775 | $21,865 | 56.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $14,520 | $6,090 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 54 | $7,560 | $3,373 | 44.6% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 13 | 14 | $7,000 | $2,844 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 743 | 1,181 | $236,200 | $123,185 | 52.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 251 | 252 | $252,000 | $110,675 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 320 | 320 | $108,800 | $45,754 | 42.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 86 | 91 | $25,025 | $14,102 | 56.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 87 | $12,180 | $6,390 | 52.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $12,320 | $5,472 | 44.4% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2022 | 12 | 12 | $6,000 | $2,480 | 41.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 726 | 1,137 | $227,400 | $126,917 | 55.8% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 176 | 178 | $178,000 | $81,623 | 45.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 302 | 302 | $102,680 | $43,667 | 42.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 114 | 124 | $34,100 | $18,908 | 55.4% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 38 | 38 | $30,400 | $14,200 | 46.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 82 | $11,480 | $5,736 | 50.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $7,040 | $2,691 | 38.2% |
| 95700 | Continuous measurement of brain wave activity (eeg), administered in person by eeg technologist | Office | 2021 | 11 | 11 | $5,500 | $2,319 | 42.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 615 | 1,015 | $195,515 | $89,773 | 45.9% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2020 | 135 | 136 | $136,000 | $56,720 | 41.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2020 | 111 | 111 | $88,800 | $39,376 | 44.3% |
About Dr. Stephanie Block, MD
Dr. Stephanie Block, MD is a Neurology healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1659698769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephanie Block, MD has received a total of $52,958 in payments from pharmaceutical and medical device companies, with $3,483 received in 2024. These payments were reported across 1,141 transactions from 70 companies. The most common payment nature is "" ($34,532).
As a Medicare-enrolled provider, Block has provided services to 5,761 Medicare beneficiaries, totaling 7,478 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Neurology
- Location Silver Spring, MD
- Active Since 04/28/2010
- Last Updated 08/24/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1659698769
Products in Payments
- KESIMPTA (Drug) $1,643
- UBRELVY (Drug) $1,395
- APTIOM (Drug) $1,041
- EMGALITY (Drug) $837.92
- NURTEC ODT (Drug) $788.45
- VYEPTI (Biological) $770.48
- QULIPTA (Drug) $668.10
- AJOVY (Biological) $665.49
- ZEPOSIA (Drug) $500.03
- AJOVY (Drug) $451.23
- Austedo XR (Drug) $442.11
- MAYZENT (Drug) $402.14
- GOCOVRI (Drug) $375.50
- AMYVID (Drug) $365.79
- VUMERITY (Drug) $339.76
- TYSABRI (Biological) $336.70
- Briviact (Drug) $284.82
- Aimovig (Biological) $282.66
- BOTOX (Biological) $275.86
- INGREZZA (Drug) $252.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Silver Spring
David Taragin, Md, MD
Neurology — Payments: $23,536
Neurology $23,536
Kenneth Eckmann, Md, MD
Neurology — Payments: $20,536
Neurology $20,536
Michael Dimyan, M.d, M.D
Neurology — Payments: $225.90
Neurology $225.90
Heather Fitter, Md, MD
Neurology
Neurology
Dr. Rosita Dee, M.d, M.D
Neurology
Neurology
Dr. Ignacio Rodriguez, Md, MD
Neurology
Neurology